Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1 - 1,000 - Monthly Reach
Unique listeners across all episodes (30 days)
1 - 5,000 - Active Followers
Loyal subscribers who consistently listen
1 - 500
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
From Legal to Leadership: Becoming a Successful Biotech CEO with Heather Turner
May 5, 2026
Unknown duration
From Physician to Biotech CEO: Building High-Impact Clinical Development with Dr. Allison Jeynes
Apr 14, 2026
Unknown duration
Capital, Courage, and Clinical Execution: Lessons from a Biotech Founder-CEO with Paul Garofolo
Mar 3, 2026
Unknown duration
Season 2 is Coming Soon
Feb 17, 2026
Unknown duration
Leadership Lessons from Biotech Innovators
Nov 19, 2025
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/5/26 | From Legal to Leadership: Becoming a Successful Biotech CEO with Heather Turner | How do you go from lawyer to biotech CEO? In this episode of Clinical Trialblazers, Heather Turner, CEO of LB Pharmaceuticals, shares her journey from legal counsel to leading a late-stage biotech company. She discusses the mindset shifts required to step into the CEO role, making high-stakes decisions with incomplete data, and balancing risk versus benefit. Heather brings more than 25 years of experience across biotech and life sciences, with a career that uniquely spans legal, operational, and executive leadership. We hope you enjoyed this week’s episode of Clinical Trialblazers. Please take a moment to rate and review this podcast wherever you listen. Special thanks to our production partner, Wonder Media Network. Our producer is Brittany Martinez, our editor is Gianna Palmer and our production assistant is Joia Putnoi. | — | ||||||
| 4/14/26 | From Physician to Biotech CEO: Building High-Impact Clinical Development with Dr. Allison Jeynes | In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Allison Jeynes, CEO of Nefro Avillion Clinical Development, to explore her remarkable journey from clinician to biotech leader. With over 30 years of experience and a track record that includes the development and approval of nearly 20 drugs, Allison shares how she built a 100% success-rate model in clinical development, and what it takes to sustain excellence in a high-risk industry. We hope you enjoyed this week’s episode of Clinical Trialblazers. Please take a moment to rate and review this podcast wherever you listen. Special thanks to our production partner, Wonder Media Network. Our producer is Brittany Martinez, our editor is Gianna Palmer and our production assistant is Joia Putnoi. | — | ||||||
| 3/3/26 | Capital, Courage, and Clinical Execution: Lessons from a Biotech Founder-CEO with Paul Garofolo | Clinical Trialblazers is back for Season Two. Host Alberto Grignolo speaks with Paul Garofolo, Co-Founder and CEO of Locus Biosciences, about the leadership mindset behind capital efficiency, resource prioritization, and disciplined execution. Drawing on Paul’s journey from global leadership roles at Patheon to founding a next-generation precision medicine company, this episode explores fundraising across market cycles, founder-friendly capital, strategic and government partnerships, and the science behind Locus’ bacteriophage-based platform aimed at tackling multidrug-resistant infections. | — | ||||||
| 2/17/26 | Season 2 is Coming Soon | Clinical Trialblazers will be back soon! Season 2 will bring together a dynamic mix of biotech innovators, executives, and industry leaders to reveal the strategy and teamwork fueling the next wave of clinical breakthroughs. Across 10 new episodes, host Alberto Grignolo will explore high-stakes decisions, unexpected hurdles, and the defining moments that shape both careers and clinical milestones. Season 2 of Clinical Trialblazers is streaming soon wherever you listen to podcasts. We hope you enjoyed this week’s episode of Clinical Trialblazers. Please take a moment to rate and review this podcast wherever you listen. Special thanks to our production partner, Wonder Media Network. Our producer is Brittany Martinez, our editor is Gianna Palmer and our production assistant is Joia Putnoi. | — | ||||||
| 11/19/25 | Leadership Lessons from Biotech Innovators | In this season finale of Clinical Trialblazers, host Alberto Grignolo reflects on key insights and themes from conversations with biotech leaders over the past year. From researchers to entrepreneurs to investors, Alberto spoke with a wide range of leaders in the biotech industry, each with a unique perspective on the evolving biotech landscape and advice for aspiring innovators. This episode is just a sampling of the many compelling stories and lessons shared in this remarkable first season. | — | ||||||
| 10/14/25 | Building Biotech Success: Insights from Venture Capitalist Dr. Geeta Vemuri | In this episode of Clinical Trialblazers, Alberto sits down with Dr. Geeta Vemuri, Founder and Managing Partner of Agent Capital. They discuss Dr. Vemuri’s journey into venture capital, offering valuable insights on what makes successful biotech companies and CEOs stand out. She also speaks about the critical balance between scientific innovation and strong management teams, the role of capital efficiency in building sustainable companies, the value of board membership, and what excites her about the future of biopharma. | — | ||||||
| 9/16/25 | Breaking Barriers in Gene Therapy: Miquel Vila-Perello's Vision for Curing Untreatable Diseases | In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Miquel Vila-Perello, Ph.D. co-founder and CEO of SpliceBio, a gene therapy company focused on treating Stargardt disease. They discuss Miquel's journey from academia to biotech, the challenges of fundraising, the importance of passion and resilience in drug development, and the future of gene therapy. Miquel shares insights on balancing rationality and passion, the differences between academic and industry research, and the significance of building trust with investors. | — | ||||||
| 8/12/25 | Investing in Innovation: Lyla Bibi’s Perspective on Biotech Markets | In this episode of Clinical Trialblazers, Lyla Bibi, Partner at Goldman Sachs and Head of Healthcare Equity Capital Markets, shares her impactful career journey focused on helping bring cutting-edge therapies to life by bridging capital and science. Tune in as she offers a behind-the-scenes look into the nuances of biotech investment in today’s competitive landscape, emphasizing the importance of a clear value proposition, the enduring power of trust in leadership, and the essential characteristics of successful biotech CEOs. Beyond the science and market trends, Lyla offers valuable insights on balancing a demanding career with a full personal life and her optimistic outlook on the future of scientific funding. | — | ||||||
| 7/15/25 | The Finnish Formula: Finding Balance and Building Innovation with Dr. Antti Vuolanto | In this episode of Clinical Trialblazers, Dr. Antti Vuolanto, CEO of Herantis Pharma Plc, shares his unconventional journey into the biotech industry, from bioengineering to leading a company focused on central nervous system (CNS) diseases. He discusses the scientific innovation behind HER096, a potential game-changer for Parkinson's disease, and the challenges of drug development. Beyond the science, Dr. Vuolanto offers profound lessons on the importance of building trust with colleagues and investors, the importance of taking risks, and the importance of work-life balance (a Finnish secret to happiness!). This episode highlights the power of mentorship, honest communication, and a deep commitment to impacting patients’ lives. He discusses the importance of mentorship, the challenges of drug development, and the significance of building trust with investors. | — | ||||||
| 6/10/25 | Leading with Science and Heart: Dr. Ross Breckenridge on Building a Resilient Biotech | In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Dr. Ross Breckenridge, CEO of Arjuna Therapeutics, a company pioneering a novel approach to precision oncology through therapeutic molecular clusters. Dr. Breckenridge shares insights on the cultural differences between academia and industry, the benefits of conducting clinical trials in Europe over the U.S., and the importance of chemistry manufacturing controls (CMC) in drug development. He also discusses the challenges of raising capital and the critical role of strong leadership to build and foster a resilient and reliable team. | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/13/25 | Bedside to Biotech: Dr. Sam Blackman on Building Trust, Storytelling in Science, and Pediatric Cancer Innovation | In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Sam Blackman, co-founder and former Chief Medical Officer of Day One Biopharmaceuticals, board member of the Pediatric Brain Tumor Foundation, Bonum Therapeutics and CureSearch for Children's Cancer, and the new Entrepreneur in Residence at Google Ventures. Sam talks about his career journey from physician to biotech executive, and navigating the complexities of clinical trials, especially within pediatric oncology. He also discusses the critical need to connect the science, patients, and investment thesis together into a coherent story when fundraising in drug development. 2:37 - How he was pulled to pediatric medicine 6:00 - His decision to transition into drug development to impact exponentially more patients. 16:40 - The importance of connecting you vision to your company name 26:04 - How making those risky decisions in drug development can have profound impacts on patient outcomes 40:00 - The Power of Storytelling in Science and Business 47:57 - Advice for biotech entrepreneurs seeking capital | — | ||||||
| 4/15/25 | From Mentee to CEO, Board Member and Mentor: Insights from Kerrie Brady | In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Kerrie Brady, Chairperson of Neurocentrx Pharmaceuticals and an Independent Board Member at Asklepion Pharmaceuticals and Invea Therapeutics. Kerrie reflects on her extensive career in the biotech and pharmaceutical industries, highlighting the importance of receiving early mentorship, cultivating relationships of trust with investors, working with your Board of Directors, reasons for joining Boards, leadership style, and navigating cultural transitions in global business. | — | ||||||
| 3/11/25 | Leading Through Setbacks with Cytokinetics’ Robert Blum | In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing. | — | ||||||
| 3/11/25 | De-Risking Clinical Trials: Michael Bailey's Patient-First Approach | In this episode of Clinical Trialblazers, Michael Bailey, President and CEO of Aveo Oncology, shares his insights on the evolving landscape of oncology trials and their impact on patient care. Join host Alberto Grignolo for a thoughtful conversation on the challenges and innovations shaping the future of clinical development. | — | ||||||
| 3/4/25 | Introducing: Clinical Trialblazers! | Step inside the world of biotech leaders as they share the untold stories behind their journeys to bring breakthrough innovations to patients. Each episode uncovers the heart, grit, and ingenuity of the people shaping the future of scientific innovation—with Parexel as their trusted partner every step of the way. Host Alberto Grignolo – Editor-in-Chief of DIA Global Forum, a DIA podcast host, and a Fellow of DIA will sit down with biotech visionaries throughout 10 episodes to talk about the challenges they have faced, the pivotal moments that have shaped their careers and the lessons they have learned along the way. We hope you enjoyed this week’s episode of Clinical Trialblazers. Please take a moment to rate and review this podcast wherever you listen. Special thanks to our production partner, Wonder Media Network. Our producer is Brittany Martinez, our editor is Gianna Palmer and our production assistant is Joia Putnoi. | — | ||||||
Showing 15 of 15
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
4 placements across 4 markets.
Chart Positions
4 placements across 4 markets.